FATE Competitors & Alternatives
Compare Fate Therapeutics Inc with similar stocks in the same industry
Biotechnology
FATE
Main Stock$1.62
Tradestie Score
37
Market Cap
$144.16M
Revenue Growth
0.1%
Analyst Upside
+254.3%
Top Competitors
219 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ALLO
Allogene Therapeutics, Inc. Common Stock
|
$0.90
|
$275.13M | - | 40 | Compare |
|
VOR
Vor Biopharma Inc. Common Stock
|
$20.07
|
$269.08M | 0.1 | 51 | Compare |
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
|
$256.71M | - | 51 | Compare |
|
NGNE
Neurogene, Inc. Common Stock
|
$25.42
|
$256.54M | - | 32 | Compare |
|
SLN
Silence Therapeutics Plc American Depository Share
|
$19.77
|
$240.89M | - | 41 | Compare |
|
OABI
OmniAb, Inc. Common Stock
|
$5.06
|
$231.77M | - | 44 | Compare |
|
SGMT
Sagimet Biosciences Inc. Series A Common Stock
|
$11.25
|
$227.00M | - | 42 | Compare |
|
SLS
SELLAS Life Sciences Group, Inc. Common Stock
|
$8.48
|
$211.22M | - | 59 | Compare |
|
ACRS
Aclaris Therapeutics, Inc.
|
$4.33
|
$202.58M | - | 34 | Compare |
|
CBIO
Crescent Biopharma, Inc. Common Stock
|
$14.58
|
$199.71M | - | 48 | Compare |
More FATE Analysis
Data updated: Nov 11, 2026 | Industry: Biotechnology (SIC 2836)
219 stocks in this industry